{
    "clinical_study": {
        "@rank": "73767", 
        "arm_group": {
            "arm_group_label": "Pancreatic cancer with liver metastases", 
            "description": "Tumor tissue biopsy, blood samples"
        }, 
        "biospec_descr": {
            "textblock": "Tumor tissue"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is a feasibility study to perform image-guided liver biopsies in 25 patients who have\n      pancreatic cancer with liver metastasis (cancer in the pancreas that has spread to the\n      liver). This will contribute with samples for the bio-bank (bank of tumors) and develop\n      xenografts (human tumors growing in mice) for further analysis of genes."
        }, 
        "brief_title": "A Study of Pancreatic Cancer in Xenografts From Liver Metastases", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pancreatic Cancer", 
            "Liver Metastases", 
            "Tumor Tissue Biopsy", 
            "Blood Samples"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasm Metastasis", 
                "Neoplasms, Second Primary", 
                "Pancreatic Neoplasms", 
                "Liver Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study might bring a better understanding of the metastatic pancreatic cancer and\n      evaluate the differences between the metastatic and the primary pancreatic cancer (the type\n      that does not have metastasis)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Minimum age of 18 years old\n\n          -  Pancreatic cancer with liver metastasis\n\n          -  No contraindication to image-guided biopsy of liver metastasis, including\n             uncontrolled bleeding diathesis, uncontrolled malignant pain, inability to lie supine\n             etc) and no significant hepatic dysfunction.\n\n          -  Provide written informed consent\n\n          -  ECOG 0,1 or 2\n\n        Exclusion Criteria:\n\n          -  Inability to lie supine for more than 30 minutes\n\n          -  ECOG 3 or more\n\n          -  Serious medical risk factors involving any of the major organ systems or including\n             uncontrolled bleeding diathesis, uncontrolled malignant pain, inability to lie supine\n             etc) and no significant hepatic dysfunction."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Pancreatic cancer patients with liver metastases"
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774643", 
            "org_study_id": "XENO-METPANC"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pancreatic cancer", 
            "Liver metastases", 
            "Tumor tissue biopsy", 
            "Blood samples", 
            "Xenografts", 
            "Murine", 
            "Genomic profiling", 
            "Circulating biomarkers"
        ], 
        "lastchanged_date": "August 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Toronto", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "M5G 2M9"
                }, 
                "name": "Princess Margaret Cancer Centre"
            }, 
            "investigator": [
                {
                    "last_name": "Malcolm J. Moore, M.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Neesha Dhani, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer", 
        "overall_contact": {
            "email": "ria.sayat@uhn.ca", 
            "last_name": "Ria Sayat"
        }, 
        "overall_official": {
            "affiliation": "Princess Margaret Cancer Centre", 
            "last_name": "Moore Malcolm, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Number of patients with adverse events due to biopsies", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Number of successful xenografts", 
                "safety_issue": "Yes", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Number of similiarities and differences between original patient tumor sample with xenograft sample", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "Engraftment rate compared to clinical data (response to treatment, disease-free survival, overall survival)", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774643"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University Health Network, Toronto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Health Network, Toronto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}